Collegium Pharmaceutical, Inc. (COLL) Stock Analysis

Free AI-powered analysis and research for Collegium Pharmaceutical, Inc. stock

Sector: Healthcare

Analyze Collegium Pharmaceutical, Inc. (COLL) Stock

Collegium Pharmaceutical, Inc. (COLL) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into COLL stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Collegium Pharmaceutical, Inc. stock.

Analyze COLL Now →

📰 Latest Update

Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference

Sat, March 14, 2026 at 6:02 PM UTC 3 min read

Collegium Pharmaceutical announced record performance for 2025 and highlighted the potential of its product JORNAY PM to drive growth in 2026 during the Barclays Miami Conference. This positive outlook is significant for investors as it indicates strong future revenue prospects and reinforces the company's strategic focus on its key products. The emphasis on JORNAY PM suggests that Collegium is well-positioned to capitalize on market opportunities in the coming years.

Read full article →